Literature DB >> 23058309

Influence of cognitive function on speech and articulation rate in multiple sclerosis.

Jonathan D Rodgers1, Kris Tjaden, Lynda Feenaughty, Bianca Weinstock-Guttman, Ralph H B Benedict.   

Abstract

We examined cognitive predictors of speech and articulation rate in 50 individuals with multiple sclerosis (MS) and 23 healthy controls. We measured speech and articulation rate from audio-recordings of participants reading aloud and talking extemporaneously on a topic of their choice (i.e., self-generated speech). Articulation rate was calculated for each speech sample by removing lexically irrelevant vocalizations and pauses of >200 ms. Speech rate was similarly calculated including pauses. Concurrently, the Minimal Assessment of Cognitive Function in Multiple Sclerosis (MACFIMS) battery, as well as standardized tests of sentence intelligibility and syllable repetition were administered. Analysis of variance showed that MS patients were slower on three of the four rate measures. Greater variance in rate measures was accounted for by cognitive variables for the MS group than controls. An information processing speed composite, as measured by the Symbol Digit Modalities Test (SDMT) and the Paced Auditory Serial Addition Test (PASAT), was the strongest predictor among cognitive tests. A composite of memory tests related to self-generated speech, above and beyond information processing speed, but not to oral reading. Self-generated speech, in this study, was not found to relate more strongly to cognitive tests than simple reading. Implications for further research are discussed.

Entities:  

Mesh:

Year:  2012        PMID: 23058309      PMCID: PMC5564302          DOI: 10.1017/S1355617712001166

Source DB:  PubMed          Journal:  J Int Neuropsychol Soc        ISSN: 1355-6177            Impact factor:   2.892


  33 in total

1.  Long-term phonatory instability in individuals with multiple sclerosis.

Authors:  L Hartelius; E H Buder; E A Strand
Journal:  J Speech Lang Hear Res       Date:  1997-10       Impact factor: 2.297

2.  Paced auditory serial-addition task: a measure of recovery from concussion.

Authors:  D M Gronwall
Journal:  Percept Mot Skills       Date:  1977-04

Review 3.  Maximum performance tests of speech production.

Authors:  R D Kent; J F Kent; J C Rosenbek
Journal:  J Speech Hear Disord       Date:  1987-11

4.  Cognitive-linguistic deficit and speech intelligibility in chronic progressive multiple sclerosis.

Authors:  Catherine Mackenzie; Jan Green
Journal:  Int J Lang Commun Disord       Date:  2009 Jul-Aug       Impact factor: 3.020

5.  Variations in articulatory movement with changes in speech task.

Authors:  Stephen M Tasko; Michael D McClean
Journal:  J Speech Lang Hear Res       Date:  2004-02       Impact factor: 2.297

6.  Characteristics of diadochokinesis in multiple sclerosis and Parkinson's disease.

Authors:  Kris Tjaden; Elizabeth Watling
Journal:  Folia Phoniatr Logop       Date:  2003 Sep-Oct       Impact factor: 0.849

7.  Prediction of neuropsychological impairment in multiple sclerosis: comparison of conventional magnetic resonance imaging measures of atrophy and lesion burden.

Authors:  Ralph H B Benedict; Bianca Weinstock-Guttman; Inna Fishman; Jitendra Sharma; Christopher W Tjoa; Rohit Bakshi
Journal:  Arch Neurol       Date:  2004-02

8.  Validity of the Beck Depression Inventory-Fast Screen in multiple sclerosis.

Authors:  R H B Benedict; I Fishman; M M McClellan; R Bakshi; B Weinstock-Guttman
Journal:  Mult Scler       Date:  2003-08       Impact factor: 6.312

9.  Multiple sclerosis.

Authors:  Alastair Compston; Alasdair Coles
Journal:  Lancet       Date:  2008-10-25       Impact factor: 79.321

10.  The utility of regression-based norms in interpreting the minimal assessment of cognitive function in multiple sclerosis (MACFIMS).

Authors:  Brett A Parmenter; S Marc Testa; David J Schretlen; Bianca Weinstock-Guttman; Ralph H B Benedict
Journal:  J Int Neuropsychol Soc       Date:  2009-10-02       Impact factor: 2.892

View more
  7 in total

1.  A first investigation of tongue, lip, and jaw movements in persons with dysarthria due to multiple sclerosis.

Authors:  Antje S Mefferd; Abish Lai; Francesca Bagnato
Journal:  Mult Scler Relat Disord       Date:  2018-10-30       Impact factor: 4.339

2.  Slowed articulation rate is a sensitive diagnostic marker for identifying non-fluent primary progressive aphasia.

Authors:  Claire Cordella; Bradford C Dickerson; Megan Quimby; Yana Yunusova; Jordan R Green
Journal:  Aphasiology       Date:  2016-07-21       Impact factor: 2.773

3.  Separate and Combined Influence of Cognitive Impairment and Dysarthria on Functional Communication in Multiple Sclerosis.

Authors:  Lynda Feenaughty; Kris Tjaden; Bianca Weinstock-Guttman; Ralph H B Benedict
Journal:  Am J Speech Lang Pathol       Date:  2018-08-06       Impact factor: 2.408

4.  Motor speech patterns in Huntington disease.

Authors:  Sarah K Diehl; Antje S Mefferd; Ya-Chen Lin; Jessie Sellers; Katherine E McDonell; Michael de Riesthal; Daniel O Claassen
Journal:  Neurology       Date:  2019-10-29       Impact factor: 9.910

5.  Profiling Speech and Pausing in Amyotrophic Lateral Sclerosis (ALS) and Frontotemporal Dementia (FTD).

Authors:  Yana Yunusova; Naida L Graham; Sanjana Shellikeri; Kent Phuong; Madhura Kulkarni; Elizabeth Rochon; David F Tang-Wai; Tiffany W Chow; Sandra E Black; Lorne H Zinman; Jordan R Green
Journal:  PLoS One       Date:  2016-01-20       Impact factor: 3.240

6.  Association between speech rate measures and cognitive function in people with relapsing and progressive multiple sclerosis.

Authors:  Clodagh O'Keeffe; Siew Mei Yap; Laura Davenport; Clodagh Cogley; Fiona Craddock; Alex Kennedy; Niall Tubridy; Céline De Looze; Narin Suleyman; Fiadhnait O'Keeffe; Richard B Reilly; Christopher McGuigan
Journal:  Mult Scler J Exp Transl Clin       Date:  2022-08-17

7.  Subcortical Effects on Voice and Fluency in Dysarthria: Observations from Subthalamic Nucleus Stimulation.

Authors:  Diana Sidtis; John J Sidtis
Journal:  J Alzheimers Dis Parkinsonism       Date:  2017-10-30
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.